Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

NCT07204977 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

NIH

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
Motor Neuron Disease

Interventions

DRUG: Acamprosate calcium

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)